Cost-effectiveness of strategies for monitoring the response to antiretroviral therapy in resource-limited settings.
Andrew N
AN
Phillips
Charles
C
Gilks
Jens D
JD
Lundgren
D044966:Anti-Retroviral Agents / Q000627:therapeutic use*; D018791:CD4 Lymphocyte Count; D003362:Cost-Benefit Analysis; D015658:HIV Infections / Q000188:drug therapy* / Q000276:immunology* / Q000401:mortality; D006801:Humans; D017063:Outcome Assessment, Health Care
D044966:Anti-Retroviral Agents